Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China · Delayed Price · Currency is CNY 58.35
+0.46 (0.79%)
Jul 31, 2026, 3:00 PM CST
Xiamen Amoytop Biotech Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,820 | 3,696 | 2,817 | 2,100 | 1,527 | 1,132 |
Revenue Growth | 29.70% | 31.18% | 34.13% | 37.55% | 34.86% | 42.61% |
Gross Profit Gross Profit Growth | 3,522 | 3,436 | 2,634 | 1,960 | 1,356 | 1,005 |
Operating Income Operating Income Growth | 1,193 | 1,214 | 930.33 | 659.88 | 360.06 | 221.64 |
Net Income Net Income Growth | 1,014 | 1,031 | 827.6 | 555.45 | 287.02 | 181.2 |
Earnings Per Share EPS Growth | 2.47 | 2.52 | 2.03 | 1.37 | 0.71 | 0.45 |
EPS Growth | 14.33% | 24.14% | 48.18% | 92.96% | 57.78% | 55.17% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
East China East China Growth | 1,343 |
Central China Central China Growth | 500.97 |
Southwest China Southwest China Growth | 678.1 |
South China South China Growth | 331.89 |
Northeast China Northeast China Growth | 124.23 |
North China North China Growth | 440.34 |
Northwest China Northwest China Growth | 254.17 |
Overseas Overseas Growth | 8.09 |
Total Total Growth | 3,680 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,087 | 1,016 | 661.79 | 670.04 | 572.02 | 481.8 |
Total Debt Total Debt Growth | 186.88 | 175.97 | 8.94 | 7.92 | 9.74 | 25.16 |
Net Cash (Debt) Net Cash Growth | 899.77 | 839.67 | 652.85 | 662.11 | 562.28 | 456.63 |
Net Cash Growth | 12.48% | 28.62% | -1.40% | 17.76% | 23.14% | 2.28% |
Net Cash Per Share Net Cash Per Share Growth | 2.19 | 2.05 | 1.60 | 1.63 | 1.39 | 1.13 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 657.02 | 729.38 | 430.63 | 512.1 | 363.16 | 234.78 |
Capital Expenditures CapEx Growth | -271.3 | -256.14 | -251.35 | -288.46 | -219.17 | -190.93 |
Free Cash Flow Free Cash Flow Growth | 385.72 | 473.23 | 179.28 | 223.64 | 143.99 | 43.85 |
Free Cash Flow Growth | 18.30% | 163.96% | -19.84% | 55.31% | 228.34% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 92.20% | 92.97% | 93.49% | 93.33% | 88.80% | 88.78% |
Operating Margin | 31.24% | 32.84% | 33.02% | 31.42% | 23.58% | 19.57% |
Pretax Margin | 29.98% | 31.80% | 33.05% | 30.50% | 23.31% | 19.01% |
Profit Margin | 26.53% | 27.91% | 29.38% | 26.45% | 18.80% | 16.00% |
FCF Margin | 10.10% | 12.80% | 6.36% | 10.65% | 9.43% | 3.87% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.620 | 0.620 | 0.620 | 0.410 | 0.213 | 0.100 |
Dividend Per Share Growth | 0% | 0% | 51.22% | 92.49% | 113.00% | 100.00% |
Dividend Yield | 1.06% | 0.75% | 0.86% | 0.80% | 0.56% | 0.35% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.65 | 33.12 | 36.06 | 38.34 | 55.18 | 65.73 |
Forward PE | 18.06 | 25.11 | 29.30 | 33.50 | 28.12 | 28.12 |
P/FCF Ratio | 61.75 | 72.18 | 166.48 | 95.23 | 109.98 | 271.61 |
PS Ratio | 6.24 | 9.24 | 10.60 | 10.14 | 10.37 | 10.52 |